Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples